Effectiveness of Low-Level Light Therapy for Vocal Fatigue
A Preliminary Efficacy Study on the Effectiveness of Low-Level Light Therapy for Vocal Fatigue
1 other identifier
interventional
22
1 country
1
Brief Summary
The goal of this phase 2 clinical trial is to examine the effectiveness of photobiomodulation in patients with vocal fatigue. The main question it aims to answer is whether photobiomodulation is able to alleviate vocal fatigue in patients with diagnosed vocal fatigue. Participants will ask to receive photobiomodulation treatment for 12 sessions over a three week period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2024
CompletedFirst Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedJuly 14, 2025
July 1, 2025
2 months
June 24, 2025
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vocal Fatigue Measure: Vocal Fatigue Index (VFI-HK)
The VFI(HK) contains 19 items in three domains (i) tiredness of voice and avoidance of voice use (ii) physical discomfort and (iii) improvement of symptoms after rest. All items are rated on a scale from zero (0, meaning "never") to four (4, meaning "always"). The score ranges from 0 to 76, with higher score indicating worst outcome.
This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).
Secondary Outcomes (3)
Vocal function measure: Voice Handicap Index - 30
This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).
Vocal Function Measure: Aerodynamic assessment
This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).
Vocal Function Measures: Acoustic voice analysis
This will be measured at baseline (pre-treatment) and within 2-weeks after the completion of treatment (post-treatment).
Study Arms (1)
Photobiomodulation arm
EXPERIMENTALInterventions
The output of the photobiomodulation device is listed as below: * Irradiation size: 15 cm × 10 cm * Dual-wavelength: 660 nm + 850 nm * Optical power density: 10 - 15 mW/cm2 * Dose density: 6J/cm2
Eligibility Criteria
You may qualify if:
- Aged over 18 years old
- Meeting the diagnosis of vocal fatigue as per the VFI-HK
- Able to make informed consent
- Have not received any voice therapy before
You may not qualify if:
- History of photoallergy
- Significant medical or chronic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Shatin, N.T., Hong Kong
Related Publications (2)
Moreno M, Calvache C, Cantor-Cutiva LC. Systematic Review of Literature on Prevalence of Vocal Fatigue Among Teachers. J Voice. 2025 Jan;39(1):105-112. doi: 10.1016/j.jvoice.2022.07.029. Epub 2022 Sep 20.
PMID: 36137877BACKGROUNDWelham NV, Maclagan MA. Vocal fatigue: current knowledge and future directions. J Voice. 2003 Mar;17(1):21-30. doi: 10.1016/s0892-1997(03)00033-x.
PMID: 12705816BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 14, 2025
Study Start
March 9, 2024
Primary Completion
May 12, 2024
Study Completion
June 12, 2024
Last Updated
July 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- June 2025
The data that support the findings of this study are available from the investigator, TL, upon reasonable request.